Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
The Department of Health - Abu Dhabi, Mass General Brigham, and International…
In the presence of H.E.Mansoor Al Mansoori, Chairman of the Department of Health –Abu Dhabiand Dr.Alireza Haghighi, Founding Director of the International Center for Genetic Disease, the Declaration of Collaboration was signed by Dr.Asma Ibrahim Al Mannaei, Executive Director of Research and Innovation Centre at the Department of Health –Abu Dhabiand by Dr.Paul Anderson, Interim Chief Academic Officer of Mass General Brigham on behalf of iCGD and Mass General Brigham...
PR Newswire
14/06/2023
Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug…
Supplemental New Drug Application (sNDA) submission based on the NAPOLI 3 Phase III trial 1 Approval would represent expansion of treatment options in an aggressive and difficult-to-treat cancer with few treatment options currently availablePARIS, FRANCE, 14 June 2023– Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental new drug application (sNDA) Onivyde® (irinotecan liposome injection) plus 5...
Nasdaq GlobeNewswire
14/06/2023
ERYTECH announces that the Commercial Court has rejected Akkadian's request to…
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes PharmaCambridge, MA (U.S.) and Lyon (France) ,June 14 , 2023 , 8:00pmCEST – ERYTECH Pharma (Nasdaq & Euronext: ERYP),announced today that the Lyon Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma. Erytech is pleased with today's order delivered by the President of...
Nasdaq GlobeNewswire
14/06/2023
Casino Group Communication
Casino Group Communication Paris, 14 June 2023Further to its press release of 24 April 2023, Casino Group announces that it has received a letter from Fimalac Group confirming that it is considering a possible participation of 150 million euros in the capital increase proposal from EP Global Commerce a.s. This press release was prepared solely for information purposes and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments...
Nasdaq GlobeNewswire
14/06/2023
GUINNESS WORLD RECORDS™ title for the "Largest human image of a human…
The safety of all participants has been a top priority for the organisers. Therefore, a group of 40 professional guides, experienced people who have coordinated countless national and international expeditions, led by David Neacșu, the mountaineer who led the first all-Romanian expedition to Everest in 2003, accompanied the participants of the medical expedition to Omu Peak. Among the other famous names who accompanied the expedition were Horia Colibășanu and Marius Gane, perhaps the most…
PR Newswire
14/06/2023
Orphan Drugs Market To Reach USD 269210 Million By 2029, Witnessing A CAGR of…
Major factors driving the growth of the Orphan Drugs Market Major factors driving the growth of the Orphan Drugs Market The Orphan Drugs Market is expanding because of favorable government regulations and an increase in the occurrence of uncommon illnesses. Increasing R&D activities will support global orphan drugs market development. During the projection period, there are likely to be lucrative prospects for market expansion due to the high growth potential in untapped emerging...
PR Newswire
14/06/2023
Beauty Devices Market Size to Grow USD 179080 Million by 2029 at a CAGR of 16% |…
Major Factors Driving the Growth of Beauty Devices Market: Major Factors Driving the Growth of Beauty Devices Market : Rising at-home beauty treatment demand, technological advancements that make these products more effective and convenient, consumer awareness of skincare and personal grooming, social media marketing of these products, the ability to customize treatments to individual needs, rising disposable income that encourages increased spending on personal care, and the growth of...
PR Newswire
14/06/2023
Medical Device Contract Manufacturing Global Market to Show Positive Growth at a…
Key Takeaways from the Medical Device Contract Manufacturing Market Report Key Takeaways from the Medical Device Contract Manufacturing Market Report To read more about the latest highlights related to the medical device contract manufacturing market, get a snapshot of the key highlights entailed in theGlobal Medical Device Contract Manufacturing Market Report Medical Device Contract Manufacturing Overview Medical Device Contract Manufacturing Organisations (CMOs) are...
PR Newswire
14/06/2023
Surgical Procedures Market worth $1,27,748.5 Thousand Procedures |…
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744 Browse in-depth TOC on "Surgical Procedures Market" 24 - Tables 27 - Figures 86 - Pages Surgical Procedures Market Scope: The emergence of COVID-19 pandemic resulted in a substantial decline in the procedural volume for most of the surgeries, however, witnessed a...
PR Newswire
14/06/2023
The Oral Solid Dosage Manufacturing Market is anticipated to grow at a steady…
Service providers have introduced the latest upgrades in their portfolio in order to achieve a competitive edge. These upgrades primarily target upstream bottlenecks related to the development and oral solid dosage manufacturing, such as low solubility, poor bioavailability, bitter taste, and high potency. Further, they also aim to streamline the manufacturing of complex formulations, including fixed dose combinations, orally disintegrating tablets, minitablets, flavored chewables, and…
PR Newswire
14/06/2023
Global Synthetic Human Secretin Market to Surpass USD 15.30 Million By 2031|…
Download PDF Sample here: https://growthmarketreports.com/request-sample/3996 Download PDF Sample here: https://growthmarketreports.com/request-sample/3996 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include types, end-user, and competitor analysis. This report also includes a complete analysis of industry players and...
PR Newswire
14/06/2023
Global Synthetic Human Secretin Market to Surpass USD 15.30 Million By 2031 |…
Download PDF Sample here: https://growthmarketreports.com/request-sample/3996 Download PDF Sample here: https://growthmarketreports.com/request-sample/3996 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include types, end-user, and competitor analysis. This report also includes a complete analysis of industry players and...
PR Newswire
14/06/2023
Global Subdermal Contraceptive Implants Market to Surpass USD 2.16 Billion By…
Download PDF Sample here: https://growthmarketreports.com/request-sample/4305 Download PDF Sample here: https://growthmarketreports.com/request-sample/4305 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include type, end-user, and competitor analysis. This report also includes a complete analysis of industry players and...
PR Newswire
14/06/2023
Global Intranasal Drug Delivery Devices Market to Surpass USD 8.11 Billion By…
Download PDF Sample here: https://growthmarketreports.com/request-sample/4227 Download PDF Sample here: https://growthmarketreports.com/request-sample/4227 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include product, dosage, application, end-user, distribution channel, and competitor analysis. This report also...
PR Newswire
14/06/2023
Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day
Attached is today's presentation held in relation to Vistin Pharma's Capital Markets Day at the Metformin manufacturing plant in Kragerø. Attachment Capital Markets Day_14_June_2023
Nasdaq GlobeNewswire
14/06/2023
MGI Partners with Xpress Genomics to Advance Deep Single-cell RNA-Sequencing…
"We are excited to finally unify quality and scale with our full-length scRNA-seq solutions", said Prof. Rickard Sandberg, co-founder of Xpress Genomics. "Building on our long-standing experience in this area, the developed technology will be streamlined into MGI's sequencing technology for the most cost-efficient and scalable full-length scRNA-seq to date." "We are excited to finally unify quality and scale with our full-length scRNA-seq solutions", said…
PR Newswire
14/06/2023
NCCN Debuts Roadmap for Improving Thyroid Cancer Care in Low- and Middle-Income…
NCCN Framework™ exists for numerous cancer types—covering more than 80 percent of cancer diagnoses—plus supportive care topics such as pain management, palliative care, and breast cancer prevention and detection. The NCCN Framework™ for Thyroid Carcinoma is the first new cancer type to be added to this library in recent years. More than 500,000 people are diagnosed with thyroid cancer worldwide every year.1 The NCCN Framework™ for Thyroid Carcinoma provides guidance on the optimal treatment…
PR Newswire
14/06/2023
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
This FIH Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic effects of MDR-001 in healthy volunteers and patients with obesity or T2DM. This FIH Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic effects of MDR-001 in healthy volunteers and patients with obesity or T2DM...
PR Newswire
14/06/2023
MGI Tech Reveals Latest Updates at ESHG Conference in Glasgow
"We are thrilled to showcase our latest achievements at the ESHG Conference, reflecting significant advancements in life science innovation. These partnerships, breakthroughs, and collaborations exemplify MGI's commitment to driving scientific progress and transforming healthcare," stated Dr. Yong Hou, General Manager of MGI Europe and Africa. "We are thrilled to showcase our latest achievements at the ESHG Conference, reflecting significant advancements in life science…
PR Newswire
14/06/2023
Single Use Support Further Expands Into US Market
Single Use Support, leading provider of fluid management and freeze-thaw logistic solutions for the biopharmaceutical industry, is excited to announce its further expansion into the United States market The company's strengthened expansion into the US market will be led by its new demo facility, scheduled to open in Q4 2023 in the area of Boston, MA. The new facility will further expand the company's US-based team, focusing on additional customer service and automation resources to ensure...
Nasdaq GlobeNewswire
14/06/2023
Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop…
Seegene's OneSystem™ Business aims to share: its syndromic quantitative PCR technologies, and Seegene's digitalized development system (SGDDS) which enables less experienced researchers to develop assays. Additionally, Seegene will provide automated manufacturing technologies to produce syndromic PCR assays compatible with Seegene's standardized OneSystem™ instruments. Seegene's OneSystem ™Business aims to share: its syndromic quantitative PCR technologies, and Seegene's digitalized...
PR Newswire
14/06/2023
Interior Health selects Hut 8 as data centre partner for co-location high…
"We've been investing in our high-performance computing business, as well as in our customers, and are proud to expand our services further into the health sector," said Josh Rayner, VP of High Performance Computing at Hut 8. "We are honoured to have been chosen as Interior Health's trusted high performance computing infrastructure provider." "We've been investing in our high-performance computing business, as well as in our customers, and are proud to expand our…
PR Newswire
14/06/2023
Point of Care Molecular Diagnostics Market worth $3.4 billion |…
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127 Browse in-depth TOC on "Point of Care Molecular Diagnostics Market" 127 - Tables 43 - Figures 212 - Pages Point of Care Molecular Diagnostics Market Scope: The Assays & Kits segment is expected to account for the largest share of the Point of Care Molecular...
PR Newswire
14/06/2023
Smart Mirror Market to be Worth $1,012.6 Million by 2030: Grand View Research…
Read full market research report, "Smart Mirror Market Size, Share & Trends Analysis Report By Installation Type (Wall Mounted, Free-Standing), By Application (Residential, Commercial), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report, " Smart Mirror Market Size, Share & Trends Analysis Report By Installation Type (Wall Mounted, Free-Standing), By Application…
PR Newswire
14/06/2023
Altri Comunicati